CheckMyRecalls

Integra LifeSciences Corp. recalls CODMAN CERTAS Plus Programmable…

Integra LifeSciences Corp. recalls CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only and 1 more

Published
29 Jan 2025
Units affected
3 products
Agency
FDA
Country
United States

The hazard

Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Model Number: 828810 Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.

CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. Model Number: 828820. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.

CODMAN CERTAS Plus Programmable Valve Inline Small Valve Only. Model Number: 828810PL. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.

Brand / company
Integra LifeSciences Corp.
Codes / lots
UDI-DI: 10381780535874. Lot Numbers: 7432470, 7434917, 7434918 and 7438322. | UDI-DI: 10381780535997. Lot Number: 7415567. | UDI-DI: 10381780535881. Lot Numbers: 7416790, 7432471, 7434929, 7434930, 7438312 and 7438313.
Distribution
US Nationwide distribution in the states of FL, NC, MA, MN, OH, DC, VA, CA, WI, NE, TX, NY, MI, OR, NJ, SC, AZ, UT, RI, IN, GA, CO and the countries of Canada, Australia, New Zealand, Cyprus, Sweden, Finland, Slovenia and Great Britain.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.